Skip to main content Skip to section navigation Skip to footer
ProMIS Neurosciences, Inc.
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Our Science
  • Product Pipeline
    • Overview
    • Alzheimer’s Disease
    • ALS
    • MSA
    • Parkinson’s Disease
    • Posters & Publications
  • News & Media
    • Press Releases
    • Events
    • In The News
    • Videos
    • Commentary
    • Podcasts
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • SEC Filings
    • Governance
  • Careers
  • Contact

Podcasts

News & Media

News & Media

  • Press Releases
  • Events
  • In The News
  • Videos
  • Commentary
  • Podcasts

Episode 18 – Dr. Sharon Cohen Deconstructs the Aducanumab Data From CTAD

Episode 19 – Dr. Stephen Salloway, Rhode Island’s Man of the Year, on a brighter future for Alzheimer’s disease

Episode 20 –Dr. José Luis Molinuevo of the BarcelonaBeta Brain Research Center on the Future of Alzheimer's Disease

*Re-Release* Episode 4 – How do Biomarkers Work?

Episode 21 – “For a COVID-19 antibody test, selectivity is key.”

Episode 22 – Worried about aducanumab? Don’t be. Dr. Jim Kupiec explains

Episode 23 – Introducing Intrabodies with Dr. Johanne Kaplan.

Episode 24 – New Ways to Attack ALS and Other Protein Misfolding Diseases with Johanne Kaplan

Episode 25 – Trusting Covid-19 antibody testing—the CDC weighs in

Episode 26 – A diagnostic test for Alzheimer’s disease

rss_feed RSS
  • arrow_back
  • 1
  • 2
  • 3
  • arrow_forward
Facebook Linkedin Spotify Twitter
©2025 ProMIS Neurosciences, Inc. All Rights Reserved.
Disclaimer Sitemap Cookie Policy Privacy Policy